Pegvisomant

Pegvisomant is a growth hormone receptor antagonist, used mainly to treat acromegaly in adults—particularly when traditional treatments like surgery, radiation, or somatostatin analogues are ineffective or unsuitable. It is grouped under the following drug class(es): Hormones. The directory classifies it as a commercial API with a biotechnology source/manufacturing origin. Other names for this substance include Somavert and Trovert. Its PubChem SID is 481101796.

CAS No 218620‑50‑9
Molecular Formula C₉₉₀H₁₅₃₂N₂₆₂O₃₀₀S₇
Molecular Weight ~45,000 Da

Frequently Asked Questions